Latest News On Cost Transparency

Latest California Healthline Stories

KHN’s ‘What the Health?’: Taking a Shot at Gun Control

The U.S. House passed a package of bills seeking to keep some guns out of the hands of children and teenagers, but its fate in the Senate remains a big question mark. Meanwhile, the Federal Trade Commission takes on drug and hospital prices. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Cori Uccello of the American Academy of Actuaries about the most recent report from Medicare’s trustees board.

Pharmacies Face Extra Audit Burdens That Threaten Their Existence

Pharmacy benefit managers have curtailed in-person audits of pharmacy claims during the pandemic, switching to virtual audits done by computer. That has markedly increased the number of claims they can review — and the chances for payment denials — squeezing pharmacies and bringing in more cash for the benefit companies.

Hospital Prices Just Got a Lot More Transparent. What Does This Mean for You?

Under a rule that kicked in Jan. 1, hospitals are required to make public the prices they negotiate with insurers. That’s a lot more information than was previously required, which was only the posting of “chargemasters” — the hospital-generated list prices that few consumers or health plans actually pay.

New Laws Keep Pandemic-Weary California at Forefront of Health Policy Innovation

Gov. Gavin Newsom approved many consequential health care bills by his bill-signing deadline Wednesday, including a ban on the sale of menthol and other flavored tobacco products, the creation of a state generic drug label and better coverage for mental health disorders.